Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PLx Pharma Inc.

www.plxpharma.com

Latest From PLx Pharma Inc.

Execs On The Move, July 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Execs On The Move, June 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Finance Watch: Surrozen Raises $33m In $483m February Flurry; Also, Are Reverse Mergers This Year's IPOs?

Surrozen raised $33m to fund drug development programs targeting Wnt ligands for various indications during a February VC financing flurry that occurred despite a drop in IPOs. Taking an alternative route to going public, some biopharma companies have completed reverse mergers in recent weeks and months.

Financing StartUps and SMEs

Execs On The Move, March 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
  • Therapeutic Areas
  • Cardiovascular
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • 1291520
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PLx Pharma Inc.
  • Senior Management
  • Natasha Giordano, Pres. & CEO
    Rita M O'Connor, CFO
    Michael J Dillon, VP, Sales & Mktg.
    Efthymios Deliargyris, MD, CMO
  • Contact Info
  • PLx Pharma Inc.
    Phone: (713) 842-1249
    8285 El Rio, Ste. 130
    Houston, TX 77054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register